Inhibrx Biosciences Financial Ratios for Analysis 2022-2024 | INBX

Fifteen years of historical annual and quarterly financial ratios and margins for Inhibrx Biosciences (INBX).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
0.410.30
--
--
100.00100.00
-9,348.04-8,769.81
-9,348.04-8,769.81
-9,275.15-8,676.65
-9,383.54-8,769.73
-9,483.72-8,769.96
0.060.08
--
2.105.12
17471.33
1,9441,580
1,9441,580
-596.02-692.85
1,9441,580
--
0.000.00
--

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-31
4.706.200.375.25----
---0.83----
---4.76----
-100.00-100.00100.00100.00--
--160,898.00--1,753.54-38,510.08-137,796.70--
--160,898.00--1,753.54-38,510.08-137,796.70--
--------
-1,858,013--1,002.15-43,518.48-156,823.30--
-1,858,011--1,111.92-43,520.17-156,840.00--
-0.00-0.00----
--------
-0.07-1.91----
-1,248-47.15----
-24.58847458-37.96----
-24.58847458-37.96----
-19.71719-174.59-5.36----
-24.58847458-6.59----
12.3315.15-0.92----
-9.74-8.130.000.00-11.58-7.540.000.00
-9.91-8.29---11.68-7.57--